|
Business |
|
Kopran (KOPRAN) is a healthcare company manufacturing pharmaceutical formulations and over-the-counter (OTC) natural products. It was incorporated on April 26, 1958 as a private limited company, converted into a public limited company on Aug. 24, 1984, and got its current name on Aug. 22, 1990. ... More.. |
|
Future Plans |
|
| CEO Talk | | Think of your heart, think Kopran. That could well be the motto of Kopran Ltd. the Indian pharma company that currently rules the roost in the domestic cardiovascular drugs market. Surendra Somani |
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 31-Dec-2014(9) | 31-Mar-2014 (12) | 31-Mar-2013 (12) | | Net sales | 2130.60 | 2941.70 | 2433.00 | | Other Income | 38.90 | 13.30 | 17.20 | | Total Income | 2169.50 | 2955.00 | 2450.20 | | Cost of goods sold | 1960.20 | 2593.00 | 2159.20 | | OPBDIT | 209.30 | 362.00 | 291.00 | | PAT | 76.40 | 170.44 | 120.60 | | Gross Block | - | - | - | | Equity capital | 411.00 | 390.50 | 390.50 | | EPS (Rs.) | - | 4.36 | 0.00 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 2.75 - 6.95 | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 9.6 | 12.3 | 11.9 | | Net margin (% of OI) | 3.5 | 5.8 | 4.9 |
|
|
Detailed Financials
|
|
|
|
|
